Advancing Cancer Research Through Collaboration
Friends aims to accelerate cutting edge cancer care that both extends and improves quality of life for patients. We leverage groundbreaking collaborations, generate scientific evidence, and integrate patient input to shape public policy
Our Projects
Advancing Cancer Research Through Collaboration
Friends aims to accelerate cutting edge cancer care that both extends and improves quality of life for patients. We leverage groundbreaking collaborations, generate scientific evidence, and integrate patient input to shape public policy
Our Projects
Advancing Cancer Research Through Collaboration
Friends aims to accelerate cutting edge cancer care that both extends and improves quality of life for patients. We leverage groundbreaking collaborations, generate scientific evidence, and integrate patient input to shape public policy
Our Projects
Advancing Cancer Research Through Collaboration
Friends aims to accelerate cutting edge cancer care that both extends and improves quality of life for patients. We leverage groundbreaking collaborations, generate scientific evidence, and integrate patient input to shape public policy
Our Projects

New Peer Reviewed Publication

White Paper | Leveraging AI-Enabled Tumor Assessment Tools on Radiological Images to Evaluate Treatment Effect and Support Clinical Trial Endpoints in Solid Tumors

Blog: Engaging Innovation

Meeting Recap | Modernizing Oncology Endpoints: Pathways for Evidence and Policy

Upcoming Events

Application of External Control Arms in Oncology Drug Development

April 7, 2026 | In-person Meeting

Our Impact

Friends of Cancer Research (Friends) unites stakeholders across healthcare to drive scientific, policy, and regulatory progress that speeds life-saving treatments to patients.

  • Research Partnerships

    Our data-driven research partnerships analyze clinical, diagnostic, and real-world data to generate evidence, convene stakeholders, and advance innovative oncology approaches that improve patient outcomes. These projects generate evidence, drive policy change, and improve patient outcomes.

  • Policy Initiatives

    Our policy & regulatory initiatives bring together stakeholders to assess emerging challenges in oncology drug development and policy to help inform recommendations for modernizing regulatory frameworks and clinical trials.

  • Analysis

    Explore Friends interactive tools for analyzing data and trends on oncology drug approvals. We hope these resources empower users to uncover their own insights and identify emerging trends.

  • Advocacy & Education

ai.RECIST Project
Learn More
ctMoniTR Project
Read More
Digital PATH Project
Learn More
ECA Pilot
Learn More
Cell & Gene Therapies
Learn More
Clinical Trial Eligibility Criteria
Read More
Interim OS Project
Learn More
Lung-MAP
Click Here
Tolerability & Dosing
Click Here
Drug Development Dashboards
Read More
Search Breakthrough Therapies
Learn More
Advisory Advocates
Learn More
Advocacy Newsletter
Learn More
Progressforpatients.org
Learn More
ProgresoparaPacientes.org
Learn More

2025 By The Numbers

Working Groups
0
Working Group Members
0 +
Publication Downloads
0 K+
Meeting Attendees
0 K+
Publication Citations
0 +

Get Involved

Join Friends by supporting our important work speeding lifesaving treatments to patients.

Subscribe
Media Inquiries
Donate
Upcoming Events